Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Lung Cancer Surgery Equipment Market Size And Revenue Outlook Through 2030
The lung cancer surgery equipment market size has experienced significant expansion over recent years. This market is anticipated to rise from $3.73 billion in 2025 to $3.98 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.7%. Historically, this growth can be ascribed to a limited supply of advanced thoracic surgery equipment, a reliance on traditional open surgeries, an increasing prevalence of lung cancer, a rising number of hospital and surgical clinics, and the adoption of standard biopsy and imaging procedures.
The market for lung cancer surgery equipment is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $5.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. This anticipated growth during the projected timeframe stems from several factors, including the advancement of robotic-assisted and less invasive surgical instruments, the incorporation of AI-powered imaging and patient monitoring technologies, increased funding directed towards research and academic institutions, the wider implementation of enhanced recovery after surgery (ERAS) protocols, and the proliferation of dedicated lung cancer treatment facilities. Key trends identified for this forecast period encompass the increasing preference for minimally invasive lung procedures, a heightened need for sophisticated imaging and diagnostic apparatus, the seamless linking of patient monitoring equipment with surgical instruments, an intensifying emphasis on post-operative recovery and subsequent care, and the broadening application of robotic-assisted thoracic surgery.
Get A Free Sample Report With In-Depth Market Insights:
Lung Cancer Surgery Equipment Market Growth Factors: What’s Supporting Expansion?
The increasing incidence of lung cancer is projected to stimulate expansion in the lung cancer surgery equipment market in the future. This condition involves the uncontrolled proliferation of anomalous cells within the lungs, typically stemming from smoking or detrimental environmental exposure. The surge in lung cancer diagnoses is primarily attributed to increased exposure to risk factors like tobacco smoke, atmospheric pollution, and workplace carcinogens, coupled with a demographic shift towards an older population. Devices for lung cancer surgery are utilized for diagnosis, excision of malignant tissue, and facilitating post-operative recovery through meticulous surgical procedures and patient surveillance. As an illustration, in February 2025, the Cancer Council, an Australia-based non-profit organization, reported that approximately 15,122 individuals in Australia received a lung cancer diagnosis in 2024, with the typical age at diagnosis standing at 72. Within the country, lung cancer holds the position of the fifth most frequently diagnosed cancer, and it is anticipated that around one in 20 Australians will be diagnosed with the condition by the age of 85. Consequently, the expanding prevalence of lung cancer is fueling the expansion of the lung cancer surgery equipment market.
Lung Cancer Surgery Equipment Market Segment Analysis And Revenue Potential
The lung cancer surgery equipment market covered in this report is segmented –
1) By Product Type: Surgical Instruments, Access Devices, Imaging Equipment, Electrosurgical Devices, Biopsy Devices, Patient Monitoring Equipment
2) By Surgery Type: Lobectomy Surgery, Pneumonectomy Surgery, Wedge Resection, Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery
3) By Application: Diagnosis, Treatment, Aftercare And Rehabilitation
4) By End User: Hospitals, Surgical Clinics, Ambulatory Surgical Centers, Research And Academic Institutes
Subsegments:
1) By Surgical Instruments: Scalpels, Forceps, Retractors, Scissors, Sutures
2) By Access Devices: Trocars, Catheters, Guidewires, Introducers
3) By Imaging Equipment: CT Scanners, MRI Machines, PET Scanners, X-Ray Systems, Ultrasound Devices
4) By Electrosurgical Devices: Electrosurgical Generators, Electrosurgical Probes, Electrosurgical Electrodes, Smoke Evacuation Systems
5) By Biopsy Devices: Needle Biopsy Devices, Core Biopsy Devices, Vacuum-Assisted Biopsy Devices, Endoscopic Biopsy Devices
6) By Patient Monitoring Equipment: Pulse Oximeters, ECG Monitors, Respiratory Monitors, Blood Pressure Monitors, Temperature Monitors
Lung Cancer Surgery Equipment Market Industry Trends: What’s Reshaping Demand?
Leading companies in the lung cancer surgery equipment market are prioritizing the development of devices for robot-assisted bronchoscopy. This focus aims to elevate the precision and safety of tumor localization and biopsy, improve accessibility to challenging lung nodules, and support the early and accurate identification of lung cancer. Robotically assisted bronchoscopy is a cutting-edge medical procedure that leverages robotic technology to guide a bronchoscope, a thin, flexible tube, into the lungs with superior precision and control compared to traditional manual methods. For instance, in March 2025, Johnson and Johnson, a US-based pharmaceutical company, announced that its MONARCH QUEST system, an advanced robotic-assisted bronchoscopy technology, achieved U.S. FDA 510(k) clearance. This system marks the latest progression of the MONARCH Platform, designed to enhance lung cancer diagnosis through minimally invasive procedures. The system integrates with the GE HealthCare OEC 3D mobile CBCT Imaging System, facilitating real-time, intraprocedural 3D imaging. This combined functionality improves the accuracy of targeting lung nodules, particularly those located in difficult-to-reach areas of the lung.
Lung Cancer Surgery Equipment Market Industry Leaders And Competitive Landscape
Major companies operating in the lung cancer surgery equipment market are Johnson & Johnson, Medtronic plc, Siemens Healthcare AG, Fujifilm Limited, GE Healthcare Technologies Inc, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, KARL STORZ GmbH & Co KG, Integra LifeSciences Corporation, Richard Wolf GmbH, Angiodynamics Inc, B Braun Melsungen AG, Sontec Instruments Inc, Novadaq Technologies Inc, Stryker Corporation, CONMED Corporation, Smith & Nephew plc, Ambu A S
View The Full Lung Cancer Surgery Equipment Market Report:
Lung Cancer Surgery Equipment Market Regional Analysis And Leading Geography
North America was the largest region in the lung cancer surgery equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.